Radiotherapy for recurrent prostate cancer: 2018 Recommendations of the Australian and New Zealand Radiation Oncology Genito-Urinary group-Reference-Cited by-同舟云学术

Radiotherapy for recurrent prostate cancer: 2018 Recommendations of the Australian and New Zealand Radiation Oncology Genito-Urinary group

Published:2018-11 Issue:2 Volume:129 Page:377-386
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Lieng Hester,Hayden Amy J.,Christie David R.H.,Davis Brian J.,Eade Thomas N.,Emmett Louise,Holt Tanya,Hruby George,Pryor David,Shakespeare Thomas P.,Sidhom Mark,Skala Marketa,Wiltshire Kirsty,Yaxley John,Kneebone Andrew

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference137 articles.

1. Contemporary update of a multi-institutional predictive nomogram for salvage radiotherapy after radical prostatectomy;Tendulkar;J Clin Oncol,2016

2. Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial;Carrie;Lancet Oncol,2016

3. Radiation with or without antiandrogen therapy in recurrent prostate cancer;Shipley;N Engl J Med,2017

4. Chemohormonal therapy in metastatic hormone-sensitive prostate cancer;Sweeney;N Engl J Med,2015

5. Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial;James;Lancet,2016

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A randomised trial of short‐ vs long‐term androgen deprivation with salvage radiotherapy for biochemical failure following radical prostatectomy: URONCOR 06‐24;BJU International;2024-07-23

2. European association of urology risk stratification predicts outcome in patients receiving PSMA-PET-planned salvage radiotherapy for biochemical recurrence following radical prostatectomy;Radiotherapy and Oncology;2024-05

3. Feasibility and Acute Toxicity of Hypo-Fractionated Radiotherapy on 0.35T MR-LINAC: The First Prospective Study in Spain;Cancers;2024-04-26

4. How to Report PSMA PET;Seminars in Nuclear Medicine;2024-01

5. The Dedicated Imaging Post‐Prostatectomy for Enhanced Radiotherapy outcomes (DIPPER) trial protocol: a multicentre, randomised trial of salvage radiotherapy versus surveillance for low‐risk biochemical recurrence after radical prostatectomy;BJU International;2023-09-14